Management of psychotropic drugs during pregnancy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26791406.
- Also identified by DOI 10.1136/bmj.h5918.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Psychiatric conditions (including substance misuse disorders) are serious, potentially life threatening illnesses that can be successfully treated by psychotropic drugs, even during pregnancy. Because few rigorously designed prospective studies have examined the safety of these drugs during pregnancy, the default clinical recommendation has been to discontinue them, especially during the first trimester. However, in the past decade, as more evidence has accumulated, it seems that most psychotropic drugs are relatively safe to use in pregnancy and that not using them when indicated for serious psychiatric illness poses a greater risk to both mother and child, including tragic outcomes like suicide and infanticide. This review presents an up to date and careful examination of the most rigorous scientific studies on the effects of psychotropic drugs in pregnancy. The lack of evidence in several areas means that definite conclusions cannot be made about the risks and benefits of all psychotropic drug use in pregnancy.
Medical subject headings
- Analgesics, Opioid
- Anti-Anxiety Agents
- Antidepressive Agents
- Antimanic Agents
- Mental Disorders
- Opiate Substitution Treatment
- Pregnancy Complications
- Selective Serotonin Reuptake Inhibitors